Point72 Hong Kong LTD Deciphera Pharmaceuticals, Inc. Transaction History

Point72 Hong Kong LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$10.11 - $16.54 $14,881 - $24,346	1,472 New	1,472 $23,000
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $82,896 - $135,460	6,696 New	6,696 $124,000
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $577 - $933	-84 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $11,311 - $54,543	-1,469 Reduced 94.59%	84 $1,000
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $41,092 - $57,693	1,553 New	1,553 $53,000
Q1 2021 May 17, 2021	SELL	$40.39 - $56.73 $23,789 - $33,413	-589 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$51.77 - $66.18 $23,400 - $29,913	-452 Reduced 43.42%	589 $34,000
Q3 2020 Nov 16, 2020	BUY	$43.8 - $58.16 $45,595 - $60,544	1,041 New	1,041 $53,000
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $24,213 - $49,968	-720 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$31.7 - $69.93 $22,475 - $49,580	709 Added 6445.45%	720 $45,000
Q3 2019 Nov 14, 2019	SELL	$19.95 - $38.85 $18,912 - $36,829	-948 Reduced 98.85%	11 $0
Q2 2019 Aug 14, 2019	BUY	$21.05 - $26.21 $20,186 - $25,135	959 New	959 $22,000
Q1 2019 May 15, 2019	SELL	$20.65 - $29.55 $536 - $768	-26 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$19.08 - $36.14 $496 - $939	26 New	26 $1,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.